N-acetylcysteine to reduce repetitive behaviors in children with autism
Treatments studied
Part of Mental health clinical trials.
This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 and 12 years old when you sign consent
- Your child must have an autism diagnosis confirmed by autism testing (like ADI-R, ADOS-2, BOSA, or CARS-2)
- Your child must have at least moderate repetitive/rigid behaviors on a autism behavior checklist (score 11 or higher)
- Your child must still be in early puberty (Tanner stage 1)
- A study doctor must say your child is medically stable and passes MRI safety checks (no metal/unsafe implants)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This study looks at whether N-acetylcysteine (NAC), a supplement/medication, can help autism-related symptoms by trying to target brain chemistry. You may be able to join if you previously took part in a related NAC study and can keep your usual medications steady.
This Phase 2 study tests whether esomeprazole helps children with autism. It looks at children who are generally healthy, take stable medicines, and can reliably attend visits so their care team can track changes during the study.
This Phase 2 study tests whether diphenhydramine improves sleep in children with autism who have significant sleep problems. It requires sleep monitoring (watch data and sleep testing) and checking for side effects to see if the treatment is safe and helpful.
This trial tests whether transcranial magnetic stimulation (a non-surgical treatment using magnets on the scalp) can reduce restricted and repetitive behaviors seen in autism. It’s designed for people with autism who have high levels of certain repetitive behaviors, like insistence on sameness or unusual interests.
This study tests whether an antioxidant supplement (something that fights cell damage) can help children with autism. It lasts 3 months and requires that the child stays on their current treatments without changes.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.